newsfilter
← Latest News
GlobeNewswire·

Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences

VICTORIA, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary